Phase III, Long-Term, Open-Label, Extension Study of 0.1% Tacrolimus(FK506) Ophthalmic Suspension in Patients With Vernal Keratoconjunctivitis
NCT00567918 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 52
Last updated 2008-04-04
Summary
To investigate the long-term efficacy and safety of FK506 ophthalmic suspension in patients with vernal keratoconjunctivitis
Conditions
- Keratoconjunctivitis
- Conjunctivitis
Interventions
- DRUG
-
FK506
Ophthalmic suspension
Sponsors & Collaborators
-
Astellas Pharma Inc
lead INDUSTRY
Principal Investigators
-
Central Contact · Astellas Pharma Inc
Study Design
- Allocation
- NA
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 6 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-05-31
- Primary Completion
- 2008-01-31
- Completion
- 2008-01-31
Countries
- Japan
Study Locations
More Related Trials
-
A Novel Combined Therapy for Refractory Vernal Keratoconjunctivitis
NCT03464435 ·Status: COMPLETED ·Phase: PHASE4
-
Evaluation of the Efficacy and Safety of Tacrolimus Drops in Children With Vernal Keratoconjunctivitis
NCT05076084 ·Status: COMPLETED
-
Safety, Tolerability, Plug Retention and Preliminary Efficacy of Tacrolimus-loaded Punctal Plug in Patients With Moderate to Severe Dry Eye Disease - Cohort B
NCT05618730 ·Status: UNKNOWN ·Phase: PHASE1
-
Topical FK506 (Tacrolimus) for Prevention of Immune Reactions Following Penetrating Keratoplasty
NCT00463723 ·Status: TERMINATED ·Phase: PHASE2/PHASE3
-
Safety and Efficacy Study of CF101 to Treat Keratoconjunctivitis Sicca
NCT00349466 ·Status: COMPLETED ·Phase: PHASE2
-
PK/PD, Safety and Tolerability of PHP-201 Topical Eye Drop in Korean and Japanese Healthy Subjects
NCT03586908 ·Status: COMPLETED ·Phase: PHASE1
-
Exploratory Study of OPC-12759 Ophthalmic Suspension
NCT01493180 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
NCT05403827 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of AK002 in Patients With Atopic Keratoconjunctivitis, Vernal Keratoconjunctivitis, and Perennial Allergic Conjunctivitis
NCT03379311 ·Status: COMPLETED ·Phase: PHASE1
-
Safety and Efficacy of Pilocarpine Ophthalmic Topical Cream for the Treatment of Dry Eye Disease
NCT05119920 ·Status: COMPLETED ·Phase: PHASE2
-
Cyclosporin A Eye Drop Treatment in Vernal Keratoconjunctivitis
NCT00426023 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical Evaluation of a Multidose Preservative-free Lubricating Eye Drops Contained in Novelia® Eye Dropper in Non-Contact Lens Wearing Patients
NCT05661851 ·Status: COMPLETED ·Phase: PHASE2
-
Evaluation of 0.05% CsA and 0.1% FK506 Eye Drops in Ocular GVHD Treatment
NCT05294666 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-term Study of DE-114 Ophthalmic Solution in Patients With Allergic Conjunctivitis
NCT01363713 ·Status: COMPLETED ·Phase: PHASE3
-
Cyclosporine 0.05% Eye Drops for Vernal Keratoconjunctivitis Trial
NCT05353101 ·Status: COMPLETED ·Phase: PHASE1
-
Povidone-iodine 2% Eye Drop Versus Artificial Tear Drop for Treatment of Adenoviral Keratoconjunctivitis
NCT04041856 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination in Adults With Seasonal Allergic Conjunctivitis
NCT05591755 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety and Pharmacokinetics of Brimonidine Tartrate 0.025%/Ketotifen Fumarate 0.035% Combination Ophthalmic Solution
NCT05815758 ·Status: COMPLETED ·Phase: PHASE3
-
Assessment of the Safety and Efficacy of BRM421 Ophthalmic Solutions in Dry Eye Subjects.
NCT05695781 ·Status: COMPLETED ·Phase: PHASE3
-
Topical rVA576 for Treatment of Atopic Keratoconjunctivitis
NCT04037891 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Evaluation of Brimonidine Tartrate/Ketotifen Fumarate Combination for the Treatment of Allergic Conjunctivitis
NCT05579730 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Rebamipide Eye Drops to Treat Dry Eye
NCT00201981 ·Status: COMPLETED ·Phase: PHASE3
-
Safety and Efficacy of Topical Tacrolimus 0.05% in the Treatment of Ocular Graft-Versus-Host Disease
NCT01977781 ·Status: COMPLETED ·Phase: PHASE1
-
Long Term Administration Study of OPC-12759 Ophthalmic Suspension
NCT00818324 ·Status: COMPLETED ·Phase: PHASE3
-
Topical Cyclosporine for Vernal Keratoconjunctivitis (VKC) in Rwanda
NCT01211327 ·Status: COMPLETED ·Phase: PHASE4